UNSPSC 51373320: Aspirin/caffeine/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373320 Aspirin/caffeine/codeine is a Commodity code showing minimal alignment with recent state and local procurement activity. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS—solicits Naloxone and safe drug deactivation systems, which fall outside the pharmaceutical combination pain-relief scope the code nominally describes. The mismatch suggests either a tagging error in the source data or a limited volume of genuine aspirin/caffeine/codeine solicitations in the recent public record.

Seminole County posted the Naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (a date discrepancy in the source), seeking 1,900 units of Naloxone and 800 deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement includes standard state and local compliance requirements—drug-free workplace certification, E-Verify compliance, workers' compensation and general liability insurance, and potential FEMA funding with attendant federal environmental compliance obligations. No set-aside designations were specified. The code shows little relevant recent activity; state and local procurement of genuine aspirin/caffeine/codeine formulations does not surface in the available opportunities block.